Skip to Content

PRASCO 327 (Phenylephrine and guaifenesin SR 30 mg / 900 mg)

Pill imprint PRASCO 327 has been identified as Phenylephrine and guaifenesin SR 30 mg / 900 mg.

Guaifenesin/phenylephrine is used in the treatment of cough and nasal congestion; sinus symptoms and belongs to the drug class upper respiratory combinations. Risk cannot be ruled out during pregnancy. Guaifenesin/phenylephrine 30 mg / 900 mg is not subject to the Controlled Substances Act.

See also related documents.

Phenylephrine and guaifenesin SR 30 mg / 900 mg PRASCO 327
Phenylephrine and guaifenesin SR
30 mg / 900 mg
Elliptical / Oval
Rx and/or OTC
Drug Class:
Upper respiratory combinations
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Prasco Laboratories

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2015, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.